Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram versus sertraline for depression
IRCT20171112037407N1Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of citalopram and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Change of depression score. Started Oct 2016; status: completed.
02
Drugs
citalopramsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20171112037407N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171112037407N1.